Best corrected visual acuity(BCVA) and central macular thickness (CMT) outcomes after fluocinolone acetonide intravitreal implant (FAc) injection in multitreated chronic diabetic macular edema (DME) patients. Efficacy in a real life setting in the United States

被引：0
|
作者：
Paez, Manuel [1 ]
Deupree, Eric William [1 ]
Tolentino, Michael John [1 ]
Deupree, Dana Madison [1 ]
机构：
[1] Macula Ctr, Retina, Miami, FL USA
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2018年 / 59卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
398
引用
收藏
页数：2
相关论文
共 18 条
  • [1] Effect of Baseline Central Retinal Thickness (CRT) and Best Corrected Visual Acuity (BCVA) on Treatment Outcomes With Intravitreal Aflibercept Injection (IAI) or Macular Laser Photocoagulation in Diabetic Macular Edema (DME)
    Ogura, Yuichiro
    Feltgen, Nicolas
    Korobelnik, Jean-Francois
    Midena, Edoardo
    Katz, Todd A.
    Teukmantel, Claudia
    Metzig, Carola
    Zeitz, Oliver
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [2] Safety and efficacy of fluocinolone acetonide intravitreal implant (Iluvien®) in patients with chronic diabetic macular edema in a real-life setting
    Santos, Monica
    Campos, Antonio
    Neves, Arminda
    Alfaiate, Pedro
    Pereira, Joana
    Castro e Sousa, Joao Paulo
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [3] Real-life visual and anatomical outcomes with fluocinolone acetonide (FAc) and cumulative cost of treatment in the treatment of chronic diabetic macular edema (DME)
    Goncalves, Rita
    Coelho, Pedro
    Teixeira, Carla
    Carvalho, Rui
    Vieira, Bruna
    Maio, Tiago
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [4] VARIATION IN RETINAL THICKNESS IN RELATION TO CORRESPONDING CHANGES IN VISUAL ACUITY IN PATIENTS RECEIVING THE FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT FOR DIABETIC MACULAR EDEMA
    Habib, Maged S.
    Holden, Sarah
    Currie, Craig
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [5] REAL-LIFE EFFICACY WITH ILUVIEN® (FLUOCINOLONE ACETONIDE [FAC]) IN DIABETIC MACULAR EDEMA (DME) PATIENTS IN 4 PORTUGUESE OPTHALMOLOGY UNITS
    Meireles, Angelina
    Pessoa, Bernardete
    Coelho, Joao
    Teixeira, Carla
    Falcao, Manuel Alberto
    Goncalves, Rita
    Silva, Marta Ines
    Castro e Sousa, Joao Paulo
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [6] CHANGES IN CENTRAL CHOROIDAL THICKNESS AFTER TREATMENT OF DIABETIC MACULAR EDEMA WITH INTRAVITREAL BEVACIZUMAB CORRELATION WITH CENTRAL MACULAR THICKNESS AND BEST-CORRECTED VISUAL ACUITY
    Nourinia, Ramin
    Ahmadieh, Hamid
    Nekoei, Elnaz
    Malekifar, Parviz
    Tofighi, Zahra
    [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 (05): : 970 - 975
  • [7] Long-term visual outcomes based on baseline vision in patients with chronic diabetic macular edema (DME) treated with fluocinolone acetonide (FAc)
    Campochiaro, Peter A.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [8] Real-world clinical outcomes after sustained delivery of the 0.19 mg fluocinolone acetonide (FAc) implant for treatment of diabetic macular edema (DME)
    Godel, Sarah
    Oncel, Damla
    Donkor, Richard
    Coney, Joseph M.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [9] Efficacy and safety of corticosteroid implant (Fluocinolone Acetonide (FAc) 0.2 lg/day, Iluvien ®) for management of Diabetic Macular Edema (DME): a real-life study
    Vieira, M.
    Pereira, J.
    Santos, M.
    Arruda, H.
    Sousa, J.
    [J]. ACTA OPHTHALMOLOGICA, 2018, 96 : 135 - 136
  • [10] Efficacy and Safety of Intravitreal Fluocinolone Acetonide Implant for Chronic Diabetic Macular Edema Previously Treated in Real-Life Practice: The REALFAc Study
    Mathis, Thibaud
    Papegaey, Maxence
    Ricard, Cecile
    Rezkallah, Amina
    Matonti, Frederic
    Sudhalkar, Aditya
    Vartin, Cristina
    Dot, Corinne
    Kodjikian, Laurent
    [J]. PHARMACEUTICS, 2022, 14 (04)
12